Our research projects

The current test for gestational diabetes can be inaccurate, expensive, inconvenient, and unappealing for many women. Professor Claire Meek wants to develop a new test that could tackle these problems. A better test could help more women with gestational diabetes to get an easier diagnosis, as well as the support they need as they go through pregnancy. 

Insulin-making beta cells respond differently to stress in women and men. Dr Aileen King wants to understand why this is, and if treatments tailored to men and women could treat both type 1 and type 2 diabetes more effectively. 

Weight gain is an important risk factor for type 2 diabetes. A lot of research studies focus on what’s happening inside fat cells to try and explain why insulin no longer works properly. Dr Kang now plans to study what’s happening just outside fat cells to find more answers and a better understanding about the link between weight gain and type 2 diabetes. 

Scientists think that gestational diabetes could be split into two main subtypes. Dr Sara White will find out if measurements of babies from ultrasound scans could be used to identify which subtype of gestational diabetes a woman has. This could help doctors to tailor and improve care, potentially reducing the risk of pregnancy complications for hundreds of thousands of women in the UK every year.

A rare type of diabetes, known as syndromic diabetes, is caused by changes in certain genes. But so far only half of the genetic changes behind the condition have been found. Dr Patel aims to find more of the genes that could be causing syndromic diabetes. This would mean more people get the right diabetes diagnosis and care.  

Women who develop type 2 diabetes under the age of 40 have a greater risk of complications during pregnancy, including stillbirth. Professor Claire Meek will explore if and how continuous glucose monitoring (CGM) can help these women to have safer pregnancies. This research could reshape future care for women with early-onset type 2 diabetes, helping to make sure they have access to the tools they need.

Beta cells have the job of making insulin, but when they’re overworked in people living with type 2 diabetes, they start to burn out. Professor Nigel Irwin is exploring a new treatment that hopes to help beta cells recharge, so they carry on making enough insulin to keep blood sugar levels on an even keel.

Our cells have engines, called mitochondria, which power them. In insulin-making cells, the mitochondria tell the cells how and when to release insulin. When blood sugar levels are high, for example when someone has type 2 diabetes, this process stops working properly. Dr Aida Martinez-Sanchez wants to investigate why this happens by studying how the gene Mtfp1 plays a part how beta cell mitochondria behave. Understanding this could help researchers to develop better treatments that may stop type 2 diabetes from progressing.

Type 1 diabetes develops when a person’s immune system attacks and destroys their insulin-making beta cells. Dr Leete will study pancreas samples from people with type 1 diabetes to figure out why the immune system turns on beta cells, and how this process may differ between people, especially those diagnosed at different ages. In the future this could lead to more personalised treatments to delay or prevent type 1 diabetes.

The brain has an important role in measuring and controlling blood sugar levels. In people with diabetes this can go wrong when the brain chooses a level that’s too high. Dr Clemence Blouet wants to find out if there’s a way of developing new treatments that can reprogramme the brain to keep blood sugar at safer levels.